Presentations: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Conference day 1

Tuesday, January 30th 2018

8:00 - 9:30, Room 1 - Main Arena 1

SYMPOSIUM: Present and future clinical use for vascular mimetic stents

supported with an educational grant from Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Enrique San Norberto-García, Jörg Teßarek, Peter Goverde
1. 08:00 - 08:07
  
  2-year data Supera popliteal real world
2. 08:07 - 08:14
  
  Supera in popliteal aneursym
3. 08:14 - 08:45
  
  Live case transmission from Leipzig
4. 08:45 - 08:52
  
  Preliminary 6-month results of VMI CFA trial
5. 08:52 - 08:59
  
  NEW DAWN: 1-year results of the combination DCBs and Supera stent for the treatment of long femoropoliteal lesions
6. 08:59 - 09:30
  
  Live case transmission from Leipzig
8:00 - 9:30, Room 2 - Main Arena 2

Acute deep vein thrombosis

Moderator:

Stephen Black, Michael Lichtenberg

Panel:

Jörn Dopheide, Christian Erbel
1. 08:00 - 08:10
  
  Pharmacomechanical thrombolysis
2. 08:10 - 08:20
  
  Catheter-directed thrombolysis
3. 08:20 - 08:30
  
  Catheter treatment of DVT: What do the guidelines say?
4. 08:30 - 08:40
  
  The ATTRACT study: View from the U.S. expert
5. 08:40 - 08:50
  
  The ATTRACT study: View of a European expert
6. 08:50 - 09:10
  
  Live case transmission from Zurich
7. 09:10 - 09:30
  
  Live case transmission from Galway
8:00 - 18:00, Scientific Posters

Electronic posters will be displayed from 08:00 – 18:00 in front of Main Arena 1
9:00 - 11:00, Room 3 - Technical Forum

Management of carotid artery disease: Remaining controversies and challenges ahead

Moderator:

Marc van Sambeek, William Gray

Panel:

Carlo Setacci, Stanislaw Bartus, Steve Ramee
1. 09:00 - 09:07
  
  Randomised data in carotid artery stenting: current evidence and future perspectives
2. 09:07 - 09:12
  
  Despite Level 1 and other evidence, the future outlook for carotid stenting is bright
3. 09:12 - 09:19
  
  The future of carotid stenting – Proximal protection and mesh-covered stents are the answer
4. 09:19 - 09:44
  
  Live case transmission from Berlin
5. 09:44 - 09:51
  
  1-year results of a new mesh-covered carotid stent: SCAFFOLD trial
6. 09:51 - 09:58
  
  The CLEAR-ROAD study: a physician-initiated study investigating the RoadSaver stent in carotid lesions (final 12-month results)
7. 09:58 - 10:05
  
  PrOspective multiCentrE study of cArotid artery steNting Using MER Stent – the OCEANUS study
8. 10:05 - 10:12
  
  Comparative analysis of new mesh-covered stent designs using MRI parameters
9. 10:12 - 10:19
  
  Plaque protrusion during carotic artery stenting: risk factors determined by MR plaque imaging
10. 10:19 - 10:26
  
  ROADSTER 2 trial: Transcervical access with reversed flow circuit for proximal protection during CAS. What have we learned so far?
11. 10:26 - 10:33
  
  Transcervical carotid stenting (TECAR) with flow reversal vs. CEA in highly symptomatic patients
12. THE GREAT DEBATE: HOW SHOULD WE HANDLE ASYMPTOMATIC CAROTID STENOSES?
13. 10:33 - 10:40
  
  Carotid repair is best for asymptomatic severe carotid stenosis because medical management alone does not work
14. 10:40 - 10:47
  
  When better NOT to treat asymptomatic carotid stenosis
15. 10:47 - 10:54
  
  ACST-2, over 2500 patients randomised; what do we know?
16. 10:54 - 11:00
  
  Discussion and conclusion
9:30 - 11:00, Room 1 - Main Arena 1

Latest results with new technologies for femoropopliteal obstructions: drug-eluting devices, atherectomy and new implants

Moderator:

Dierk Scheinert

Panel:

Marianne Brodmann, Thomas Zeller, Steven Kum, Wei Guo
1. 09:30 - 09:35
  
  EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions
2. 09:35 - 09:40
  
  ILLUMENATE EU RCT: 2-year results with the Stellarex DCB in femoropopliteal lesions
3. 09:40 - 09:45
  
  FIRST TIME DATA RELEASE: CONSEQUENT RCT: 2-year results with the SeQuent Please OTW DCB
4. 09:45 - 09:50
  
  FIRST TIME DATA RELEASE: IN.PACT Japan RCT of DCB vs. PTA: 2-year results
5. 09:50 - 09:55
  
  FIRST TIME DATA RELEASE: ILLUMENATE GLOBAL: 2-year results of the Stellarex DCB in femoropoliteal lesions
6. 09:55 - 10:00
  
  DANCE trial (ATX and PTA groups) – 2-year results
7. 10:00 - 10:05
  
  Long term durability of DCB treatment in the SFA: 4-year results of the IN.PACT SFA study
8. 10:05 - 10:10
  
  Outcomes of DCB use in real-world patients: 2-year results from the IN.PACT global registry
9. 10:10 - 10:15
  
  FIRST TIME DATA RELEASE: LUTONIX long lesion study: 2-year outcomes
10. 10:15 - 10:20
  
  FIRST TIME DATA RELEASE: COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions
11. 10:20 - 10:25
  
  FIRST TIME DATA RELEASE: Outcomes of DCB use in femoropopliteal lesions of patients with CLI (RCC4/5): Subgroup analysis of IN.PACT global study
12. PROMISE AND LIMITATIONS OF DCB – WHAT HAVE WE LEARNED?
13. 10:25 - 10:30
  
  DCB from a preclinical perspective: The relevance of paclitaxel dose and coating integrity
14. 10:30 - 10:35
  
  DCB from a clinical perspective: What is proven and where are the open questions and limitations?
15. 10:35 - 10:40
  
  Panel discussion
16. 10:40 - 10:45
  
  Update on the TOBA studies in the femoropopliteal arteries
17. 10:45 - 10:50
  
  FIRST TIME DATA RELEASE: LOCOMOTIVE All Comers Study with the VascuFlex Multi-LOC spot stenting device: 12-month results
18. 10:50 - 10:55
  
  FIRST TIME DATA RELEASE: 1-year results from the MIMICS-2 Study; US, German, and Japanese experience with the BioMimics 3D stent
19. 10:55 - 11:00
  
  Discussion and conclusion
9:30 - 11:00, Room 2 - Main Arena 2

Management of complex aortoliliac disease: Avoiding complications and optimizing outcomes

Moderator:

Lawrence Garcia, Ramon Varcoe

Panel:

Patrice Mwipatayi, Jörn Balzer, Peter Goverde, Chris Metzger
1. 09:30 - 09:36
  
  Endovascular treatment of occlusive aortic disease with abdominal stent grafts
2. 09:36 - 09:42
  
  Contemporary stenting of the abdominal aorta for steno-occlusive disease: new technical developments
3. 09:42 - 09:47
  
  Mid-term outcome of CERAB for aorto-iliac occlusive disease
4. 09:47 - 10:10
  
  Live case transmission from Cotignola
5. 10:10 - 10:16
  
  Experience after 500 endoluminal stent grafts. Devices specific outcome and lessons learned.
6. 10:16 - 10:21
  
  LIFESTREAM™ – First look at the BOLSTER two year follow up data
7. 10:21 - 10:26
  
  Improving the treatment of complex iliac occlusive disease: 24-month results from the VBX FLEX trial show sustained clinical benefits in complex patient subsets
8. 10:26 - 10:54
  
  Live case transmission from Leipzig
9. 10:54 - 11:00
  
  Prevention and management of vascular complications related to transcatheter aortic valve implantation
10:30 - 12:00, Room 5 - Global Expert Exchange

CCT@LINC

Moderator:

Giancarlo Biamino, Kazushi Urasawa

Panel:

Hiroshi Ando, Tatsuya Nakama, Osamu Iida
1. 10:30 - 10:40
  
  Introduction
2. 10:40 - 10:55
  
  Video live and lecture: How to cross below-the-knee CTO
3. 10:55 - 11:10
  
  Video live and lecture: How to cross below-the-ankle CTO
4. 11:10 - 11:25
  
  Video live and lecture: How to cross SFA CTO/Japanese evidences
5. 11:25 - 11:40
  
  Video live and lecture: How to cross SFA CTO/Japanese techniques
6. 11:40 - 12:00
  
  Discussion and conclusion
11:00 - 12:30, Room 1 - Main Arena 1

SYMPOSIUM: Patient first: “Leave the right thing behind”. Debating evidence to provide the answers

supported with an educational grant from COOK Medical

Moderator:

Iris Baumgartner-Peuker

Panel:

Thomas Zeller, Fabrizio Fanelli, Aloke Finn, Marc Bosiers
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:13
  
  XPEDITE study
3. 11:13 - 11:21
  
  DCB + BMS is not a DES
4. 11:21 - 11:41
  
  Live case transmission from Leipzig
5. 11:41 - 11:49
  
  Understanding restenosis in the SFA
6. 11:49 - 11:57
  
  First results of the ZILVERPASS study
7. 11:57 - 12:17
  
  Live case transmission from Jena
8. 12:17 - 12:25
  
  The importance of scientific evidence
9. 12:25 - 12:30
  
  Summing up on symposium discussion and debate
11:00 - 12:30, Room 2 - Main Arena 2

Venous stenting

Moderator:

Houman Jalaie, Robert Lookstein

Panel:

Michael Lichtenberg, Christian Erbel
1. 11:00 - 11:15
  
  Live case transmission from Zurich
2. 11:15 - 11:30
  
  Live case transmission from Galway
3. 11:30 - 11:40
  
  Clinical results of venous stents
4. 11:40 - 11:50
  
  Clinical results of a dedicated May Thurner stent
5. 11:50 - 12:00
  
  Anticoagulation after stenting for acute deep vein thrombosis
6. 12:00 - 12:15
  
  Live case transmission from Zurich
7. 12:15 - 12:30
  
  Live case transmission from Galway
11:00 - 12:30, Room 3 - Technical Forum

The challenge ahead: How to improve acute stroke management

Moderator:

William Gray, Karl-Titus Hoffmann

Panel:

Marco Roffi, Bernhard Reimers
1. 11:00 - 11:07
  
  Periprocedural neurologic complications during CAS: How to manage
2. 11:07 - 11:14
  
  Acute stroke management – What is state of the art?
3. 11:14 - 11:21
  
  Acute stroke treatment: How I do it
4. 11:21 - 11:26
  
  A single centre experience in stroke treatment with EmboTrap II: Technology based on Clot research
5. 11:26 - 11:36
  
  Case reviews
6. 11:36 - 11:43
  
  Reality of stroke management in Germany and how to proceed
7. 11:43 - 11:50
  
  From interventional cardiology to cardio-neurology. A new sub-speciality in the future?
8. 11:50 - 12:16
  
  Live case transmission from Cotignola
9. 12:16 - 12:23
  
  Early results of the PERFORMANCE I study assessing the safety and feasibility of a 3-in-1 carotid stenting sytem with integrated embolic protection
10. 12:23 - 12:30
  
  Experience with bilateral carotid filter protection during percutaneous aortic valve replacement
12:30 - 13:30, Room 1 - Main Arena 1

Lunch
12:30 - 13:25, Room 2 - Main Arena 2

LUNCH SYMPOSIUM: Vascular protection in patients with peripheral artery disease (PAD): Improving outcomes with dual pathway inhibition – The COMPASS study

supported with an educational grant from Bayer AG

Moderator:

Dierk Scheinert

Panel:

Sebastian Debus, Uwe Zeymer, Rupert Bauersachs
1. 12:30 - 12:35
  
  Opening remarks
2. 12:35 - 12:45
  
  Vascular protection in patients with CAD and PAD: New options
3. 12:45 - 12:55
  
  From registries to clinical trials: impact on guidelines for PAD
4. 12:55 - 13:10
  
  PAD: From post-intervention to the chronic state
5. 13:10 - 13:25
  
  Question and Answer
12:30 - 13:30, Room 4 - Discussion Forum

My selection of guidewire and support catheter for complex BTK procedures

supported with an educational grant from Asahi Intecc

Moderator:

Kazushi Urasawa
1. Guide wire selection
2. Guide wire selection
3. Support catheter selection
12:30 - 13:30, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD/ BTK/ CLI

Moderator:

Jihad Mustapha

Panel:

Miguel Montero-Baker, Steven Kum
1. 12:30 - 12:35
  
  36-month results from the absorb BTK study
2. 12:35 - 12:40
  
  6-month results of real-life use of the latest generation of balloon expandable DES in below-the-knee treatment
3. 12:40 - 12:45
  
  Below-the-knee balloon angioplasty with and without non-selective stem cells infusion in treatment of critical limb ischemia
4. 12:45 - 12:50
  
  Statin therapy and amputation-free survival in CLI patients: insights from the CRITISCH registry
5. 12:50 - 12:55
  
  Peroneal artery angioplasty as a single runoff vessel for foot revascularisation in patients with critical limb ischemia
6. 12:55 - 13:00
  
  Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries. 12-month results of the BIOLUX P-III all comers registry in critical limb ischemia patients
7. 13:00 - 13:05
  
  1-year outcomes of peripheral vascular intervention in critical limb ischemia patients: Sub-analysis of the LIBERTY 360 study
8. 13:05 - 13:10
  
  Update on the BEST-CLI trial
9. 13:10 - 13:15
  
  The relation of 2D perfusion angiography after below-the-knee intervention and wound healing in patients with critical limb ischemia – single center prospective study
10. 13:15 - 13:20
  
  Interim results from the OMNIA study – utilisation of micro oxygen sensors during CLI therapy
11. 13:20 - 13:30
  
  Discussion and conclusion
12:30 - 13:30, Room 7 - Speakers' corner

Selected abstracts original research – EVAR part I

Moderator:

Weiguo Fu

Panel:

Ralph-Ingo Rückert, Ramon Varcoe
1. 12:30 - 12:35
  
  Cardiac- and respiratory-induced motion of renal arteries and stents in snorkel endovascular aneurysm sealing
2. 12:35 - 12:40
  
  30-day mortality and re-interventions after open and endovascular repair of intact and ruptured abdominal aortic aneurysms in Korea: Based on HIRA data
3. 12:40 - 12:45
  
  Outcomes after one-stage vs. two-stage open repair of Type II thoracoabdominal aortic aneurysm
4. 12:45 - 12:50
  
  The impact of endovascular aneurysm repair on short and long term renal function
5. 12:50 - 12:55
  
  Total endovascular techniques utilisation in aortic dissection radical treatment
6. 12:55 - 13:00
  
  A single center experience using automated intracranial pressure-controlled cerebrospinal fluid external drainage
7. 13:00 - 13:05
  
  Endovascular treatment of giant abdominal aortic aneurysms
8. 13:05 - 13:10
  
  Effect of remote ischemic preconditioning in the incidence of contrast induced nephropathy in patients undergoing EVAR (RIP-EVAR STUDY)
9. 13:10 - 13:15
  
  12-year experience with the treatment of aortoiliac and isolated iliac aneurysms by the iliac branch devices: Results of the pELVIS registry
10. 13:15 - 13:20
  
  The Image-Fusion using 2D-3D registration method helps to reduce the used contrast medium, fluoroscopic, and procedural time in TEVAR procedures
11. 13:20 - 13:30
  
  Discussion and conclusion
12:35 - 13:20, Room 3 - Technical Forum

LUNCH SYMPOSIUM: Unmet needs in EVAR: do they exist?

supported with an educational grant from Cardinal Health

Moderator:

Giovanni Torsello

Panel:

Giovanni Pratesi, Jean-Pierre Becquemin
1. 12:35 - 12:52
  
  Unmet needs in EVAR: case and discussion
2. 12:52 - 13:09
  
  Percutaneous technique for EVAR: case and discussion
3. 13:09 - 13:16
  
  Latest clinical results from INCRAFT™ AAA Stent Graft – 5 years of data
4. 13:16 - 13:20
  
  Discussion and conclusion
12:35 - 13:20, Room 5 - Global Expert Exchange

LUNCH SYMPOSIUM: DCB or stent? The latest data to influence your decision

supported with an educational grant from iVascular

Moderator:

Koen Deloose
1. 12:35 - 12:43
  
  Luminor DCB makes it different and favourable in CLI (LUMINOR registry, 12-month data)
2. 12:43 - 12:51
  
  Is there still any space left for DES? (ANGIOLITE BTK trial, 6-month data)
3. 12:51 - 12:58
  
  Discussion: BTK
4. 12:58 - 13:06
  
  Is Luminor DCB the best choice for femoropopliteal lesions? (EFFPAC–RCT, 6-month data)
5. 13:06 - 13:14
  
  Or is the iVolution stent a better alternative? (EVOLUTION study, 12-month data)
6. 13:14 - 13:20
  
  Femoropopliteal arteries discussion
13:00 - 14:40, Scientific Posters

Moderated poster round: Challenging cases: AV, iliac, venous

Juror:

Christian Erbel, Marcus Treitl
1. 13:00 - 13:05
  
  Acute thrombosis complicating aneurysmal fistula salvage
2. 13:05 - 13:10
  
  Endovascular management for salvage of arteriovenous fistula
3. 13:10 - 13:15
  
  Bilateral endovascular interventions after crossover bypass grafting
4. 13:15 - 13:20
  
  Persistent sciatic artery aneurysm, case report and follow-up for 15 years
5. 13:20 - 13:25
  
  Successful of hybrid revascularisation for TASC D AIOD after failing femoro-femoral crossover bypass
6. 13:25 - 13:30
  
  Percutaneous revascularization could be a feasible option for complex aorto-iliac occlusive disease (case presentation)
7. 13:30 - 13:35
  
  Complex ilio-femoral revascularization with a Gore® Hybrid Vascular Graft
8. 13:35 - 13:40
  
  Endovascular treatment of calcified, stenotic iliac arteries
9. 13:40 - 13:45
  
  Innovative use of covered stents in acute lower limb ischaemia due to aorto iliac occlusions – two case reports
10. 13:45 - 13:50
  
  Guidewire related complication during hemodialysis catheter placement: Intravascular knotted guidewire
11. 13:50 - 13:55
  
  Superior vena cava filter placement for prevention of pulmonary embolism due to acute upper extremity deep venous thrombosis in patients contra-indicated anticoagulation
12. 13:55 - 14:00
  
  Catheter directed thrombolysis for treatment of bilateral Iliofemoral deep venous thrombosis with hypoplastic inferior vena cava
13. 14:00 - 14:05
  
  Endovascular Treatment of deep venous thrombus due to May-Thurner syndrome using self-expandable stents. 4 case series with intravascular ultrasound findings
14. 14:05 - 14:10
  
  Acute deep vein thrombosis with duplication of inferior vena cava
15. 14:10 - 14:15
  
  Successful treatment of acute thrombosis (2 days ago) of left subclavian vein with initial chronic occlusion of the left brachiocephalic vein by combination CDT and balloon angioplasty described veins
16. 14:15 - 14:20
  
  A case of successful endovascular treatment of acute BT-shunt thrombosis
17. 14:20 - 14:25
  
  A successful intervention with catheter-directed thrombolysis for patient with upper-extremity deep vein thrombosis
18. 14:25 - 14:30
  
  Reconstruction of acquired IVC interruption
19. 14:30 - 14:35
  
  Endoprosthesis and hypogastric thrombosis after prothrombin complex concentrate administration – a real nightmare
20. 14:35 - 14:40
  
  Endovascular solution to a tumor-induced occlusion of iliac vessels
13:30 - 15:00, Room 1 - Main Arena 1

Leave nothing behind 2.0: Combination therapy to advance SFA treatment strategy

supported with an educational grant from Medtronic

Moderator:

Dierk Scheinert

Panel:

Krishna Rocha-Singh, Wei Guo
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  SFA disease management: Are the longterm outcomes with IN.PACT DCB changing the peripheral landscape?
3. 13:45 - 14:05
  
  Live case transmission from New York
4. 14:05 - 14:15
  
  Dose matters: Understanding the science behind DCB outcomes
5. 14:15 - 14:25
  
  From Chocolate to Hawk: Vessel preparation for improved outcomes
6. 14:25 - 14:45
  
  Live case transmission from Cotignola
7. 14:45 - 15:00
  
  Discussion and conclusion
13:30 - 15:00, Room 2 - Main Arena 2

SCRUB-IN WITH THE EXPERTS: Endovascular therapy of chronic deep vein obstructions

live from Zurich:

Nils Kucher

live from Galway:

Gerard O'Sullivan

Moderator:

Erin Murphy

Panel:

Yvonne Bausback, Stephen Black, Rick de Graaf, Tim Sebastian, Houman Jalaie
1. FLASH PRESENTATION: Complex iliocaval reconstruction with steel alloy stents
2. FLASH PRESENTATION: Complex iliocaval reconstruction with nitinol stents
3. FLASH PRESENTATION: Endophlebectomy of the common femoral vein
13:30 - 15:00, Room 3 - Technical Forum

SCRUB-IN WITH THE EXPERTS: Focus on vessel preparation and stenting strategies for complex lesions

partially supported with an educational grant from B. Braun

live from Leipzig:

Andrej Schmidt, Sven Bräunlich

Moderator:

Tony Das, Torsten Fuß

Panel:

Klaus Amendt, Brian DeRubertis, Ulf Teichgräber
1. FLASH PRESENTATION: Vessel preparation prior to DCB or stenting: How to do it
2. 13:45 - 13:50
  
  Clinical benefits of the Vanguard IEP peripheral balloon angioplasty system with integrated embolic protection from the ENTRAP study
3. 13:50 - 14:00
  
  Recorded case presentation: DETOUR procedure overview
4. SPOT STENTING & DCB: IT'S TIME TO UNDRESS THE FULL METAL JACKET
5. FLASH PRESENTATION: Fempop treatment: Long stents vs. short stents
6. FLASH PRESENTATION: Spot stenting with VascuFlex Multi-LOC
7. FLASH PRESENTATION: Combination therapy: DCB & spot stents in fempop lesions
13:30 - 14:30, Room 4 - Discussion Forum

New GORE® VIABAHN® VBX Balloon Expandable: Expert forum

supported with an educational grant from Gore & Associates

Moderator:

Andrew Holden
1. Advantages of an indication for the GORE® VIABAHN® VBX Balloon Expandable: technical and clinical value in treating aorto-iliac disease
2. Results from the VBX the IDE study and case experience
3. Case experience in aortic disease
4. Discussion
13:30 - 15:00, Room 5 - Global Expert Exchange

Clinical approaches and techniques in the management of CLI diabetic patients

partially supported with an educational grant from Alvimedica

Moderator:

Marco Manzi, Gary Ansel

Panel:

Eric Ducasse, Francesco Liistro
1. 13:30 - 13:38
  
  The specifics of diabetic macroangiopathy: What is different from atherosclerosis and how does it contribute to critical limb ischemia?
2. 13:38 - 13:44
  
  The multidisciplinary approach in BTK intervention in DM patients: the right road to success
3. 13:44 - 13:50
  
  Factors affecting outcome of CLI procedures
4. 13:50 - 13:56
  
  Timing is all in CLI diabetic patients: planning a winning strategy for limb salvage
5. 13:56 - 14:16
  
  Live case transmission from Berlin
6. 14:16 - 14:24
  
  Latest techniques and results in BTK interventions
7. DEBATE ON STUDY RESULTS VS. DAILY PRACTICE IN BTK INTERVENTIONS:
8. 14:24 - 14:30
  
  Use of DCB in BTK – CONTRA
9. 14:30 - 14:36
  
  Use of DCB in BTK – PRO
10. 14:36 - 14:42
  
  Use of DES in BTK – CONTRA
11. 14:42 - 14:48
  
  Use of DES in BTK – PRO
12. 14:48 - 14:54
  
  Is 2018 the right moment to try to harmonize BTK intervention approaches?
13. 14:54 - 15:00
  
  Are the coronary outcomes of BVS relevant to BTK applications?
13:30 - 15:00, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD/ aortoiliac/ femoral

Moderator:

Oliver Schlager

Panel:

Theodosios Bisdas, Marcus Thieme
1. 13:30 - 13:35
  
  Midterm outcome of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease
2. 13:35 - 13:40
  
  The BeGraft study: A physician-initiated study investigating the BeGraft peripheral stent graft in the iliac arteries (final 24-month results)
3. 13:40 - 13:45
  
  XTRACT as a potential frontline treatment in peripheral arterial thromboembolism – results from the multicenter PRISM trial
4. 13:45 - 13:50
  
  Impact of patient and lesion characteristics on drug coated balloon angioplasty of the femoro-popliteal artery – pooled analysis of four randomized controlled multicentre trials
5. 13:50 - 13:55
  
  Local and distal ptx effect: pre-clinical results with different DCBs
6. 13:55 - 14:00
  
  Long term results of >200 patients with the Aperto® DCB from the Italian Aperto registry
7. 14:00 - 14:05
  
  Interim report of the BIOFLEX-COF RCT, comparing high vs. low chronic outward force of nitinol stents in the SFA
8. 14:05 - 14:10
  
  A French experience of ambulatory intervention for endovascular treatment of peripheral artery disease: a retrospective study
9. 14:10 - 14:15
  
  A randomised comparison of digital subtraction angiography and kinetic imaging
10. 14:15 - 14:20
  
  The influence of balloon inflation time in femoropopliteal and BTK angioplasty: a systematic review
11. 14:20 - 14:25
  
  Tibial velocities duplex ultrasound characterisation and validity of the ankle-deep femoral artery index in peripheral arterial disease
12. 14:25 - 14:30
  
  Use of Paclitaxel-Coated Luminor® balloon catheter in the superficial femoral and popliteal arteries – the solo DEB registry
13. 14:30 - 14:35
  
  BIOFLEX – PEACE registry 24-month analysis
14. 14:35 - 14:40
  
  The Münster all-comers registry of Eluvia drug-eluting stent: 1-year outcomes
15. 14:40 - 14:45
  
  BATTLE RCT. Bare metal stent vs. drug eluting stent for SFA intermediate lesions. 6-month results
16. 14:45 - 14:50
  
  Interim 30-day analysis from the KANSHAS 1 study of the novel KANSHAS drug coated balloon for treatment of femoropopliteal occlusive disease; a latest first-in-human study
17. 14:50 - 14:55
  
  Peripheral aneurysm coiling using large volume ruby coils: Results from the multicenter ACE registry
18. 14:55 - 15:00
  
  Discussion and conclusion
13:30 - 15:00, Room 7 - Speakers' corner

Selected abstracts original research – EVAR part II

Moderator:

Marc van Sambeek

Panel:

Wolfgang Ritter
1. 13:30 - 13:35
  
  Deployment of bare stent reduce the pressure of false lumen in acute aortic dissection: Animal model and computer simulation
2. 13:35 - 13:40
  
  Complications in target arteries of branched and fenestrated stent grafts – incidence and management
3. 13:40 - 13:45
  
  Thirty day outcomes favor fenestrated repair of complex abdominal aortic aneurysms
4. 13:45 - 13:50
  
  Initial experience with the E-Iiac® iliac branch device for the endovascular aortic repair of aorto-iliac aneurysms
5. 13:50 - 13:55
  
  Open repair of proximal abdominal aneurysms classified according to the equivalent fenestrated endovascular treatment
6. 13:55 - 14:00
  
  Individualised patient decision making promotes favorable outcomes in endovascular therapy for blunt traumatic aortic injury
7. 14:00 - 14:05
  
  Mid-term outcomes of flared iliac limb used for combined common iliac artery aneurysm during endovascular aneurysm repair
8. 14:05 - 14:10
  
  The Candy-Plug technique using an Excluder aortic cuff – clinical utility and technical aspects
9. 14:10 - 14:15
  
  Evaluation of visible spinal arteries on CT angiography before and after branched stent graft repair for thoracoabdominal aortic aneurysm
10. 14:15 - 14:20
  
  Aneurysm of visible spinal arteries on CT angiography before and after branched stent graft repair for thoracoabdominal aortic aneurysm
11. 14:20 - 14:25
  
  Outcome of thoracic endovascular aortic repair with single aortic arch chimney in high risk patients
12. 14:25 - 14:30
  
  The outcome of the AFX ENDOLOGIX endograft in the prevention of Type II endoleak
13. 14:30 - 14:35
  
  Endovascular treatment of thoracoabdominal aortic aneurysm using multi-branched stent-grafts in the real world
14. 14:35 - 14:40
  
  How we deal with aortic endograft infection
15. 14:40 - 14:45
  
  Immediate, delayed, and late spinal cord ischemia after extended endovascular thoracoabdominal aortic repair
16. 14:45 - 15:00
  
  Discussion and conclusion
14:45 - 16:05, Scientific Posters

Original research: AV, iliac, renal, venous and miscellaneous

Juror:

Steve Ramee, Eberhard Wedell
1. 14:45 - 14:50
  
  10 year follow up of thrombosed AV fistula salvage: An endovascular first approach
2. 14:50 - 14:55
  
  Endovascular management of failing arteriovenous fistula
3. 14:55 - 15:00
  
  Balloon-assisted AV access maturation
4. 15:00 - 15:05
  
  Short-term outcomes of endovascular treatment of aorto-iliac occlusive disease
5. 15:05 - 15:10
  
  Comparison of standard renal denervation procedure versus novel distal and branch vessel procedure with brachial arterial access
6. 15:10 - 15:15
  
  Urgent endovascular treatment of renal hemorrage: our experience in the last 5 years
7. 15:15 - 15:20
  
  Clinical and procedural outcomes between ultra-sound accelerated thrombolysis and catheter directed thrombolysis for treatment of acute pulmonary embolism
8. 15:20 - 15:25
  
  Efficacy and safety of duplex-guided polidocanol foam sclerotherapy for venous malformations
9. 15:25 - 15:30
  
  The cost-saving potential of endovenous laser ablation (ETA) of truncal varicose veins in Switzerland
10. 15:30 - 15:35
  
  Impact of training on endovascular interventions for thrombosis in large veins
11. 15:35 - 15:40
  
  Role of Inferior vena cava filter insertion prior to thrombolysis of acute ilio femoral deep venous thrombosis
12. 15:40 - 15:45
  
  Skipped lesion at Iliocaval confluence: another technique for stenting in chronic venous obstructions
13. 15:45 - 15:50
  
  Detecting stent geometry changes after venous recanalisation using duplex ultrasound
14. 15:50 - 15:55
  
  Endovascular treatment of visceral artery aneurysm – a single center experience
15. 15:55 - 16:00
  
  A novel embolic with minimal catheter adhesion properties: GPX by Fluidx Medical Technology
16. 16:00 - 16:05
  
  Transcatheter plug occlusion for various complications after cardiac/thoracic aortic surgery
15:00 - 16:30, Room 1 - Main Arena 1

SYMPOSIUM: Going further with drug eluting technology in peripheral arterial disease: From SFA to below the knee challenges.

supported with an educational grant from Boston Scientific

Moderator:

Dierk Scheinert

Panel:

Marc Sapoval, Hans van Overhagen, Jihad Mustapha
1. 15:00 - 15:03
  
  Opening and learning objectives
2. 15:03 - 15:10
  
  Current data and performance of drug eluting technology in SFA
3. 15:10 - 15:17
  
  BTK intervention with drug coated balloons. Past lessons and future exploration
4. 15:17 - 15:47
  
  Live case transmission from Leipzig
5. 15:47 - 15:54
  
  Drug eluting stents in BTK intervention – a review
6. 15:54 - 16:01
  
  Next steps in drug eluting stent for BTK intervention
7. 16:01 - 16:08
  
  Clinical targets and patient outcome goals in BTK intervention
8. 16:08 - 16:25
  
  Panel discussion
9. 16:25 - 16:30
  
  Closing remarks
15:00 - 16:30, Room 2 - Main Arena 2

SYMPOSIUM: Nightmares in the cathlab – My worst case and how I solved it

supported with an educational grant from Terumo

Moderator:

Koen Deloose

Panel:

Yann Gouëffic, Andrea Kahlberg
1. 15:00 - 15:05
  
  Introduction
2. 15:05 - 15:25
  
  SFA with distal embolization case
3. 15:25 - 15:45
  
  FP cases
4. 15:45 - 16:05
  
  BTK CLI cases
5. 16:05 - 16:25
  
  CAS cases
6. 16:25 - 16:30
  
  Conclusions
15:00 - 16:30, Room 3 - Technical Forum

SYMPOSIUM: Minimal is optimal in SFA therapy, reducing metal burden

supported with an educational grant from BIOTRONIK

Moderator:

Jos van den Berg

Panel:

Claus Nolte-Ernsting, Lieven Maene
1. 15:00 - 15:05
  
  Introduction by the moderator
2. 15:05 - 15:15
  
  BIOLUX P-III: Passeo-18 Lux all-comers registry: 12-month results for the all-comers cohort
3. 15:15 - 15:25
  
  BIOFLEX PEACE: Pulsar-18 all-comers registry: 12- and 24-month results
4. 15:25 - 15:45
  
  Live case transmission from Berlin
5. 15:45 - 15:55
  
  BIOLUX 4EVER: Combining Passeo-18 Lux DCB and Pulsar-18 BMS: 12-month results of full cohort
6. 15:55 - 16:15
  
  Live case transmission from Leipzig
7. 16:15 - 16:25
  
  BIOTRONIK REACT: REsponse Adapted Combination Therapy: When and where to stent – concept for a pilot study
8. 16:25 - 16:30
  
  Closing by the moderator
15:00 - 16:00, Room 4 - Discussion Forum

Technical and practical aspects of highend embolo therapy

sponsored by Medtronic

Moderator:

Walter Wohlgemuth, René Müller-Wille
1. Classification of vascular anomalies and its implication on therapies
2. Embolo therapy of peripheral AVMs
3. Treatment of pulmonary AVMs
4. Minimal invasive therapy of endoleaks
5. Discussion
15:00 - 16:30, Room 5 - Global Expert Exchange

CLI-Therapies-LINCed – Multidisciplinary case studies from centres of excellence

Moderator:

Marianne Brodmann, Steven Kum

Panel:

Osamu Iida, Michiel Schreve
1. MANAGING THE INFECTED WOUND
2. 15:00 - 15:12
  
  How do you prioritize revascularisation vs. treatment of infection – presentation and a case example
3. 15:12 - 15:18
  
  Questions and answers
4. ANGIOSOME DIRECTED THERAPY
5. 15:18 - 15:30
  
  Angiosome concept – myth or truth? Does it make a real difference in “real world” cases? Presentation and a case example
6. 15:30 - 15:36
  
  Questions and answers
7. THE "MOTHER OF ALL CLIs" – THE RUTHERFORD 6 WOUND
8. 15:36 - 15:48
  
  Managing R6 wounds – the utility of multi-vessel revascularisation and inflow strategies – presentation and a case example
9. 15:48 - 15:54
  
  Questions and answers
10. CLI IN DIALYSIS – A SPECIAL BREED OF PATIENTS
11. 15:54 - 16:06
  
  Plantar arch and below-the-ankle angioplasty – who, when, and how? Presentation and a case example
12. 16:06 - 16:12
  
  Questions and answers
13. END STAGE NO OPTION CLI – MAKING SWEET DESSERT OUT OF THE DESERT FOOT
14. 16:12 - 16:24
  
  Percutaneous deep venous arterialisation with the LimFlow procedure – presentation and a case example
15. 16:24 - 16:30
  
  Questions and answers
15:00 - 16:30, Room 6 - Speakers' corner

Update on clinical trials and new data – AV access/ venous/ embolisation/ EVAR

Moderator:

Konstantinos Katsanos

Panel:

Frans Moll, Jan Brunkwall
1. 15:00 - 15:05
  
  ACCESS PTS study: ACCElerated thrombolySiS for Post-Thrombotic Syndrome using the Acoustic Pulse Thrombolysis EkoSonic® Endovascular System – midterm results of a multi-center study.
2. 15:05 - 15:10
  
  Prospective, randomised controlled study of paclitaxel-coated vs. plain balloon angioplasty for the treatment of failing dialysis access
3. 15:10 - 15:15
  
  VasQTM improves functional maturation: Randomised controlled multinational study results
4. 15:15 - 15:20
  
  The Lutonix® global AV registry real world patients with a dysfunctional AV dialysis access – interim 6-month outcomes
5. 15:20 - 15:25
  
  DCB in vascular access – where does it work
6. 15:25 - 15:30
  
  AIDA study: prophylactic onlay mesh implantation prevents incisional hernia following AAA repair. Results from a multicenter randomised trial with 2-year follow up
7. 15:30 - 15:35
  
  Large access hole vascular closure device based on fully absorbable patch, results of the frontier III trial
8. 15:35 - 15:40
  
  Prevention of Acute Kidney Injury (AKI) following Endovascular Abdominal Aortic Aneurysm Repair (EVAR) using bicarbonate and aggressive hydration: the HYDRA-P randomised controlled trial
9. 15:40 - 15:45
  
  Prospective study of the E-liac stent graft system in patients with common iliac artery aneurysm: 12-month results
10. 15:45 - 15:50
  
  Global post-market clinical follow-up of the Treovance stent-graft for endovascular abdominal aortic aneurysm repair: final results from the RATIONALE registry
11. 15:50 - 15:55
  
  Anatomical applicability of current off-the-shelf branched endograft in thoracoabdominal aortic aneurysms managed by open surgery
12. 15:55 - 16:00
  
  A post-approval registry of the TREO stent-graft for patients with infrarenal abdominal aortic aneurysms
13. 16:00 - 16:05
  
  The Italian multi-centre experience of fenestrated Anaconda™ endograft for juxta/para-renal aortic aneurysms
14. 16:05 - 16:10
  
  The use of chimney grafts in the treatment of type Ia endoleaks after previous endovascular aneurysm repair: mid-term outcomes from the PERICLES registry
15. 16:10 - 16:30
  
  Discussion and conclusion
15:00 - 16:30, Room 7 - Speakers' corner

Selected abstracts original research – PVD/ BTK/ CLI

Moderator:

Iris Baumgartner-Peuker

Panel:

Sabine Steiner
1. 15:00 - 15:05
  
  Occlusion of the radial artery. Reality or myth
2. 15:05 - 15:10
  
  Multi-centre European experience in the use of the Indigo vacuum-assisted thrombectomy system in acute limb ischemia: the ReOpen registry
3. 15:10 - 15:15
  
  Visceral Artery Aneurysms (VAAs) – Management, surveillance and natural history analysis in a single UK centre over 10 years
4. 15:15 - 15:20
  
  Validation of new oszillometric PAOD parameters: Puls Wave Index (PWI), Tissue Optical Perfusion Pressure (TOPP) and oszillometric ABI vs. cw-Doppler-ABI
5. 15:20 - 15:25
  
  Single center experience for peripheral arterial interventions via percutaneous brachial artery access using a 4F sheath
6. 15:25 - 15:30
  
  Vascular complications after extracorporeal membrane oxygenation (ECMO)
7. 15:30 - 15:35
  
  Assessment of endovascular treatment for critical lower limb ischaemia in 321 consecutive patients
8. 15:35 - 15:40
  
  Routine screening coronary angiography examination and adequate coronary revascularisation is important for improvement of clinical outcomes of patients with critical limb ischemia
9. 15:40 - 15:45
  
  WIfI classification does not predict limb amputation risk in dialysis patients undergoing revascularisation for critical limb ischemia
10. 15:45 - 15:50
  
  Non-calcified steno-obstructive lesions of adbominal aorta are associated with worse results following endovascular treatment
11. 15:50 - 15:55
  
  New approach for the development and stratification of peripheral stents
12. 15:55 - 16:00
  
  Analysis of outcomes for bioresorbable vascular Scaffold use for the treatment of infra-popliteal disease
13. 16:00 - 16:05
  
  Early clinical results of the FLEX catheter in the treatment of below the knee lesions
14. 16:05 - 16:30
  
  Discussion and conclusion
16:30 - 18:00, Room 1 - Main Arena 1

Advanced solutions for calcified lesions and CTOs

Moderator:

Ramon Varcoe, Thomas Zeller

Panel:

Richard Heuser, Gunnar Tepe, Andrew Holden, Krishna Rocha-Singh, Darren Schneider, Arne Schwindt
1. 16:30 - 16:36
  
  Vessel preparation: What does it mean and what are the current tools (PTA, DA and scoring balloons)?
2. 16:36 - 16:41
  
  Impact of chronic total occlusion on outcomes: IN.PACT global CTO imaging cohort
3. 16:41 - 17:02
  
  Live case transmission from New York
4. 17:02 - 17:08
  
  Understanding the challenges with measuring calcium in DCB clinical trials
5. 17:08 - 17:14
  
  Vascular calcium: new pre-clinical models and new treatment solutions
6. 17:14 - 17:19
  
  Clinical experience with the Phoenix atherectomy system for complex calcified lesions
7. 17:19 - 17:25
  
  Applications of Lithoplasty for the treatment of calcified lesions
8. 17:25 - 17:30
  
  Shockwave Lithoplasty System treatment of calcified lesions: Intravascular OCT analysis
9. 17:30 - 17:50
  
  Live case transmission from Leipzig
10. 17:50 - 17:55
  
  The “Crack and Pave” technique for highly resistant calcified lesions: Initial results
11. 17:55 - 18:00
  
  Discussion and conclusion
16:30 - 18:00, Room 2 - Main Arena 2

SCRUB-IN WITH THE EXPERTS: Endovascular treatment of central venous stenosis of the chest

live from Zurich:

Nils Kucher

live from Galway:

Gerard O'Sullivan

Moderator:

Robert Lookstein, Stephen Black

Panel:

Ulf Teichgräber, Bart Dolmatch, Raghu Kolluri, Rick de Graaf
1. FLASH PRESENTATION: Drug-coated balloons for the treatment of symptomatic central venous stenosis
2. FLASH PRESENTATION: Interventional techniques for central venous stenosis of the chest
3. FLASH PRESENTATION: COVERA™ – First look at the AVeVA study update for treatment of venous anastomotic lesions in AV grafts and an update on the AVeNEW trial design for outflow stenosis in AV fistula circuits
16:30 - 18:00, Room 3 - Technical Forum

SCRUB-IN WITH THE EXPERTS: Carotid interventions

live from Leipzig:

Andrej Schmidt

live from Cotignola:

Fausto Castriota, Antonio Micari

Moderator:

Giancarlo Biamino, Gary Ansel

Panel:

Martin Storck, Carlo Setacci, Maria Antonella Ruffino
1. FLASH PRESENTATION: Current consideration for patient oriented revascularisation strategies: CAS vs. CEA vs. medical management
2. FLASH PRESENTATION: How to integrate latest technology to make carotid stenting safer
3. FLASH PRESENTATION: Latest clinical experience with integrated embolic protection during CAS and future directions
4. FLASH PRESENTATION: Combined carotid and coronary revascularisation: Is this a good idea?

Notice

LINC 2018 presentations

Conference day 1

SYMPOSIUM: Present and future clinical use for vascular mimetic stents

2-year data Supera popliteal real world

Supera in popliteal aneursym

Live case transmission from Leipzig

Preliminary 6-month results of VMI CFA trial

NEW DAWN: 1-year results of the combination DCBs and Supera stent for the treatment of long femoropoliteal lesions

Live case transmission from Leipzig

Acute deep vein thrombosis

Pharmacomechanical thrombolysis

Catheter-directed thrombolysis

Catheter treatment of DVT: What do the guidelines say?

The ATTRACT study: View from the U.S. expert

The ATTRACT study: View of a European expert

Live case transmission from Zurich

Live case transmission from Galway

Electronic posters will be displayed from 08:00 – 18:00 in front of Main Arena 1

Management of carotid artery disease: Remaining controversies and challenges ahead

Randomised data in carotid artery stenting: current evidence and future perspectives

Despite Level 1 and other evidence, the future outlook for carotid stenting is bright

The future of carotid stenting – Proximal protection and mesh-covered stents are the answer

Live case transmission from Berlin

1-year results of a new mesh-covered carotid stent: SCAFFOLD trial

The CLEAR-ROAD study: a physician-initiated study investigating the RoadSaver stent in carotid lesions (final 12-month results)

PrOspective multiCentrE study of cArotid artery steNting Using MER Stent – the OCEANUS study

Comparative analysis of new mesh-covered stent designs using MRI parameters

Plaque protrusion during carotic artery stenting: risk factors determined by MR plaque imaging

ROADSTER 2 trial: Transcervical access with reversed flow circuit for proximal protection during CAS. What have we learned so far?

Transcervical carotid stenting (TECAR) with flow reversal vs. CEA in highly symptomatic patients

THE GREAT DEBATE: HOW SHOULD WE HANDLE ASYMPTOMATIC CAROTID STENOSES?

Carotid repair is best for asymptomatic severe carotid stenosis because medical management alone does not work

When better NOT to treat asymptomatic carotid stenosis

ACST-2, over 2500 patients randomised; what do we know?

Discussion and conclusion

Latest results with new technologies for femoropopliteal obstructions: drug-eluting devices, atherectomy and new implants

EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions

ILLUMENATE EU RCT: 2-year results with the Stellarex DCB in femoropopliteal lesions

FIRST TIME DATA RELEASE: CONSEQUENT RCT: 2-year results with the SeQuent Please OTW DCB

FIRST TIME DATA RELEASE: IN.PACT Japan RCT of DCB vs. PTA: 2-year results

FIRST TIME DATA RELEASE: ILLUMENATE GLOBAL: 2-year results of the Stellarex DCB in femoropoliteal lesions

DANCE trial (ATX and PTA groups) – 2-year results

Long term durability of DCB treatment in the SFA: 4-year results of the IN.PACT SFA study

Outcomes of DCB use in real-world patients: 2-year results from the IN.PACT global registry

FIRST TIME DATA RELEASE: LUTONIX long lesion study: 2-year outcomes

FIRST TIME DATA RELEASE: COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions

FIRST TIME DATA RELEASE: Outcomes of DCB use in femoropopliteal lesions of patients with CLI (RCC4/5): Subgroup analysis of IN.PACT global study

PROMISE AND LIMITATIONS OF DCB – WHAT HAVE WE LEARNED?

DCB from a preclinical perspective: The relevance of paclitaxel dose and coating integrity

DCB from a clinical perspective: What is proven and where are the open questions and limitations?

Panel discussion

Update on the TOBA studies in the femoropopliteal arteries

FIRST TIME DATA RELEASE: LOCOMOTIVE All Comers Study with the VascuFlex Multi-LOC spot stenting device: 12-month results

FIRST TIME DATA RELEASE: 1-year results from the MIMICS-2 Study; US, German, and Japanese experience with the BioMimics 3D stent

Discussion and conclusion

Management of complex aortoliliac disease: Avoiding complications and optimizing outcomes

Endovascular treatment of occlusive aortic disease with abdominal stent grafts

Contemporary stenting of the abdominal aorta for steno-occlusive disease: new technical developments

Mid-term outcome of CERAB for aorto-iliac occlusive disease

Live case transmission from Cotignola

Experience after 500 endoluminal stent grafts. Devices specific outcome and lessons learned.

LIFESTREAM™ – First look at the BOLSTER two year follow up data

Improving the treatment of complex iliac occlusive disease: 24-month results from the VBX FLEX trial show sustained clinical benefits in complex patient subsets

Live case transmission from Leipzig

Prevention and management of vascular complications related to transcatheter aortic valve implantation

CCT@LINC

Introduction

Video live and lecture: How to cross below-the-knee CTO

Video live and lecture: How to cross below-the-ankle CTO

Video live and lecture: How to cross SFA CTO/Japanese evidences

Video live and lecture: How to cross SFA CTO/Japanese techniques

Discussion and conclusion

SYMPOSIUM: Patient first: “Leave the right thing behind”. Debating evidence to provide the answers

Introduction

XPEDITE study

DCB + BMS is not a DES

Live case transmission from Leipzig

Understanding restenosis in the SFA

First results of the ZILVERPASS study

Early results of the PERFORMANCE I study assessing the safety and feasibility of a 3-in-1 carotid stenting sytem with integrated embolic protection